Daratumumab in Patients With Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits

Authors :: Brad H. Rovin
Anjali A. Satoskar
Isabelle Ayoub
Nidhi Sharma
Naresh Bumma
Salem Almaani
Samir V. Parikh
Yvonne Efebera
Source :: Kidney International Reports
Publication Year :: 2021
Publisher :: Elsevier, 2021.

Subjects :: Bortezomib
business.industry
Daratumumab
Monoclonal immunoglobulin
Glomerulonephritis
medicine.disease
daratumumab
MGRS
PGNMID
Refractory
Nephrology
Immunology
medicine
Research Letter
In patient
business
medicine.drug

Tools